125 related articles for article (PubMed ID: 26396710)
21. Epidemiology and outcomes of nasopharyngeal carcinoma: Experience from a regional cancer center in Southern India.
Haleshappa RA; Thanky AH; Kuntegowdanahalli L; Kanakasetty GB; Dasappa L; Jacob L
South Asian J Cancer; 2017; 6(3):122-124. PubMed ID: 28975121
[TBL] [Abstract][Full Text] [Related]
22. Incidence of nasopharyngeal carcinoma in Belgrade during the period 1991-2005.
Nesić V; Sipetić S; Vlajinac H; Miljus D; Stosić-Divjak S; Jesić S
Vojnosanit Pregl; 2009 Jun; 66(6):473-6. PubMed ID: 19583146
[TBL] [Abstract][Full Text] [Related]
23. Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology.
Arnold M; Wildeman MA; Visser O; Karim-Kos HE; Middeldorp JM; Fles R; Bing Tan I; Coebergh JW
Oral Oncol; 2013 Mar; 49(3):237-43. PubMed ID: 23089459
[TBL] [Abstract][Full Text] [Related]
24. Time Trend Analysis of Cancer Incidence in Caspian Sea, 2004 - 2009: A Population-based Cancer Registries Study (northern Iran).
Salehiniya H; Ghobadi Dashdebi S; Rafiemanesh H; Mohammadian-Hafshejani A; Enayatrad M
Caspian J Intern Med; 2016; 7(1):25-30. PubMed ID: 26958329
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of Nasopharyngeal Carcinoma in Sarawak, East Malaysia.
Wong KY; Basri H; Wong YL; Wahab M; Haji Kipli NP; Niap I; Ooi CH
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2817-2822. PubMed ID: 37642069
[TBL] [Abstract][Full Text] [Related]
26. A National Study of Survival Trends and Conditional Survival in Nasopharyngeal Carcinoma: Analysis of the National Population-Based Surveillance Epidemiology and End Results Registry.
Lv JW; Huang XD; Chen YP; Zhou GQ; Tang LL; Mao YP; Li WF; Lin AH; Ma J; Sun Y
Cancer Res Treat; 2018 Apr; 50(2):324-334. PubMed ID: 28421724
[TBL] [Abstract][Full Text] [Related]
27. Trends of skin cancer incidence in 6 geographical regions of the Islamic Republic of Iran, 2000-2005.
Heidari M; Najafi F
East Mediterr Health J; 2013 Jan; 19(1):59-65. PubMed ID: 23520907
[TBL] [Abstract][Full Text] [Related]
28. Third Epidemiological Analysis of Nasopharyngeal Carcinoma in the Central Region of Japan from 2006 to 2015.
Kanno M; Narita N; Fujimoto Y; Wakisaka N; Yoshizaki T; Kodaira T; Makita C; Sato Y; Yamazaki K; Wakaoka T; Shimode Y; Tsuji H; Kito R; Ishinaga H; Hosokawa S; Takakura H; Nishimura K; Matoba T; Fujieda S
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31443218
[TBL] [Abstract][Full Text] [Related]
29. [The value of plasma EBV-DNA testing in high-risk group of nasopharyngeal carcinoma in the nasal endoscopy].
He XF; Yu X; Ji MF; Fu MY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 May; 31(10):770-773. PubMed ID: 29771040
[No Abstract] [Full Text] [Related]
30. Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy: A Population-Based Cohort Study.
Fan CY; Lin CS; Chao HL; Huang WY; Su YF; Lin KT; Tsai IJ; Kao CH
Radiother Oncol; 2017 Jun; 123(3):394-400. PubMed ID: 28532605
[TBL] [Abstract][Full Text] [Related]
31. Trends in the Incidence of Nasopharyngeal Cancer in Saudi Arabia Across One Decade (2007 to 2016).
Kabli AF; Miyajan KF; Alqurashi AS; Mandili AK; Mujahed RM; Hafiz BF; Mandora RM; Herabi AZ
Cureus; 2022 May; 14(5):e24732. PubMed ID: 35673310
[TBL] [Abstract][Full Text] [Related]
32. Differential features of nasopharyngeal carcinoma in children and adults: a SEER study.
Sultan I; Casanova M; Ferrari A; Rihani R; Rodriguez-Galindo C
Pediatr Blood Cancer; 2010 Aug; 55(2):279-84. PubMed ID: 20582982
[TBL] [Abstract][Full Text] [Related]
33. No incidence trends and no change in pathological proportions of nasopharyngeal carcinoma in Zhongshan in 1970-2007.
Wei K; Xu Y; Liu J; Zhang W; Liang Z
Asian Pac J Cancer Prev; 2010; 11(6):1595-9. PubMed ID: 21338202
[TBL] [Abstract][Full Text] [Related]
34. A Retrospective Cohort Study of Nasopharyngeal Carcinoma Screening and Hepatocellular Carcinoma Screening in Zhongshang City.
Yu X; Ji M; Cheng W; Wu B; Lian S; Du Y; Cao S
J Cancer; 2019; 10(8):1909-1914. PubMed ID: 31205549
[No Abstract] [Full Text] [Related]
35. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
36. Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area.
Liu Z; Chang ET; Liu Q; Cai Y; Zhang Z; Chen G; Huang QH; Xie SH; Cao SM; Shao JY; Jia WH; Zheng Y; Liao J; Chen Y; Lin L; Liang L; Ernberg I; Vaughan TL; Adami HO; Huang G; Zeng Y; Zeng YX; Ye W
Cancer; 2017 Jul; 123(14):2716-2725. PubMed ID: 28241094
[TBL] [Abstract][Full Text] [Related]
37. [The following-up study of high-risk and moderate-risk groups defined by EB virus serology test at the nasopharyngeal carcinoma screening programme].
Lian S; Ji M; Wu B; Yu X
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jan; 49(1):26-30. PubMed ID: 25876491
[TBL] [Abstract][Full Text] [Related]
38. Thyroid Cancer Epidemiology in Iran: a Time Trend Study.
Safavi A; Azizi F; Jafari R; Chaibakhsh S; Safavi AA
Asian Pac J Cancer Prev; 2016; 17(1):407-12. PubMed ID: 26838247
[TBL] [Abstract][Full Text] [Related]
39. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality.
Lee AW; Foo W; Mang O; Sze WM; Chappell R; Lau WH; Ko WM
Int J Cancer; 2003 Feb; 103(5):680-5. PubMed ID: 12494479
[TBL] [Abstract][Full Text] [Related]
40. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.
Xu XF; Lu RQ; Xiao R; Zhou L; Zhao XM; Hu XC; Gao X; Guo L
Cancer Biomark; 2016; 16(3):467-76. PubMed ID: 27062704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
